Drug maker Abbvie recently won a court case in which they sued Takeda Pharmaceutical, the company responsible for the production of their drug Lupron. In the case, Abbvie alleges that Takeda created a shortage of the drug by intermittently shutting down one of its plants. A judge found that Takeda Takeda was in breach of its contract with Abbvie and has ordered the to pay most of the $480.6 million it sought. Lupron may sound familiar to you because it has been at the center of the debate art whether or not children should be allowed to suppress puberty to...
